2seventy bio, Inc. (TSVT) Misses Q1 EPS by 26c

2seventy bio, Inc. (NASDAQ: TSVT) reported Q1 EPS of ($1.01), $0.26 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $12.4 million versus the consensus estimate of $14.8 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c